Insider Buying of Radius Health (RDUS) Shares Extends the Trend of Last 90 Days

Friday, September 15, 2017 10:15 PM ET

Insider Buying of Radius Health (RDUS) Shares Extends the Trend of Last 90 Days

The level of buy/sell trading at Radius Health is is above the 266 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 298 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for Radius Health insiders was also higher. Within the peer group there were 7,660,539 shares purchased and 16,440,105 shares sold with company insiders having sold 29,462 shares on average.

Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data obtained in creating and writing this story.

Today’s Insider Activity
* Biotech Growth N V, 10% Owner, bought 150,000 shares
* Jose Carmona, Officer, bought 3,000 shares
* Jesper Hoiland, Director and Officer, bought 6,100 shares

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.